115
Views
0
CrossRef citations to date
0
Altmetric
Perspective

Clinical trials for neuroregenerative therapies for spinal cord injury: what have we learnt so far?

, ORCID Icon & ORCID Icon
Pages 487-499 | Received 21 Feb 2023, Accepted 15 May 2023, Published online: 26 May 2023

References

  • Paralysis statistics [Internet]. Reeve Found. [cited 2023 Apr 25]. Available from: https://www.christopherreeve.org/living-with-paralysis/stats-about-paralysis.
  • Singh A, Tetreault L, Kalsi-Ryan S, et al. Global prevalence and incidence of traumatic spinal cord injury. Clin Epidemiol. 2014;6:309–331.
  • Hejrati N, Fehlings MG. A review of emerging neuroprotective and neuroregenerative therapies in traumatic spinal cord injury. Curr Opin Pharmacol. 2021;60:331–340.
  • Facts and Figures 2020.Pdf [Internet]. [cited 2022 Dec 19]. Available from: https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%202020.pdf.
  • Tuszynski MH, Steeves JD, Fawcett JW, et al. Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP Panel: clinical trial inclusion/exclusion criteria and ethics. Spinal Cord. 2007;45(3):222–231. DOI:10.1038/sj.sc.3102009
  • Goetz C, Dupoux A, Déloy L, et al. La recherche clinique hors des centres hospitaliers universitaires : état des lieux dans l’inter-région Est. Revue d’Épidémiologie et de Santé Publique. 2015;63(2):135–141. DOI:10.1016/j.respe.2014.12.019
  • Dimond EP, St Germain D, Nacpil LM, et al. Creating a “culture of research” in a community hospital: strategies and tools from the national cancer institute community cancer centers program. Clin Trials Lond Engl. 2015;12(3):246–256. DOI:10.1177/1740774515571141
  • Lightfoot N, Strasser R, Maar M, et al. Challenges and rewards of health research in northern, rural, and remote communities. Ann Epidemiol. 2008;18(6):507–514. DOI:10.1016/j.annepidem.2007.11.016
  • Wang M, Dolovich L, Holbrook A, et al. Factors that influence community hospital involvement in clinical trials: a qualitative descriptive study. J Eval Clin Pract. 2022;28(1):79–85. DOI:10.1111/jep.13583
  • Griswold DP, Khan AA, Chao TE, et al. Neurosurgical randomized trials in low- and middle-income countries. Neurosurgery. 2020;87(3):476–483. DOI:10.1093/neuros/nyaa049
  • Tropeano MP, Spaggiari R, Ileyassoff H, et al. Traumatic spine injury: which discrepancy between the research output and the actual burden of the disease? World Neurosurg. 2020;142:e117–125.
  • Furlan JC, Sakakibara BM, Miller WC, et al. Global incidence and prevalence of traumatic spinal cord injury. Can J Neurol Sci J Can Sci Neurol. 2013;40(4):456–464. DOI:10.1017/S0317167100014530
  • Nordin M. SPINE20 – a global advocacy group to reduce disability and improve function of spine patients. J Spine Pract JSP. 2022;70–74. DOI:10.18502/jsp.v1i2.11380
  • Kim H, Cutter GR, George B, et al. Understanding and preventing loss to follow-up: experiences from the spinal cord injury model systems. Top Spinal Cord Inj Rehabil. 2018;24(2):97–109. DOI:10.1310/sci2402-97
  • Kristman V, Manno M, Côté P. Loss to follow-up in cohort studies: how much is too much? Eur J Epidemiol. 2004;19(8):751–760.
  • Middleton JW, Dayton A, Walsh J, et al. Life expectancy after spinal cord injury: a 50-year study. Spinal Cord. 2012;50(11):803–811. DOI:10.1038/sc.2012.55
  • Silberholz EA, Brodie N, Spector ND, et al. Disparities in access to care in marginalized populations. Curr Opin Pediatr. 2017;29(6):718–727. DOI:10.1097/MOP.0000000000000549
  • Pratt B. Inclusion of marginalized groups and communities in global health research priority-setting. J Empir Res Hum Res Ethics JERHRE. 2019;14(2):169–181.
  • McCarthy EA, O’Brien ME, Rodriguez WR. Training and HIV-Treatment scale-up: establishing an implementation research agenda. PLOS Med. 2006;3(7):e304.
  • Barthélemy EJ, Hackenberg AEC, Lepard J, et al. NeurotraumA surveillance in national registries of low- and middle-income countries: a scoping review and comparative analysis of data dictionaries. Int J Health Policy Manag. 2021;11:2373–2380.
  • Lukas H, Xu C, Yu Y, et al. Emerging telemedicine tools for remote covid-19 diagnosis, monitoring, and management. ACS Nano. 2020;14(12):16180–16193. DOI:10.1021/acsnano.0c08494
  • Bambs CE, Kip KE, Mulukutla SR, et al. Sociodemographic, clinical, and psychological factors associated with attrition in a prospective study of cardiovascular prevention: the heart strategies concentrating on risk evaluation study. Ann Epidemiol. 2013;23(6):328–333. DOI:10.1016/j.annepidem.2013.02.007
  • Nadal C, Sas C, Doherty G. Technology acceptance in mobile health: scoping review of definitions, models, and measurement. J MED INTERNET RES. 2020;22(7):e17256.
  • Musukuma M, Sonkwe B, Fwemba I, et al. The use of multiple imputation techniques on short-term clinical complications of patients presenting with traumatic spinal cord injuries. Open Public Health J. 2019;12(1):45–55. DOI:10.2174/1874944501912010045
  • Huque MH, Carlin JB, Simpson JA, et al. A comparison of multiple imputation methods for missing data in longitudinal studies. BMC Med Res Methodol. 2018;18(1):168. DOI:10.1186/s12874-018-0615-6
  • The 2019 revision of the International Standards for Neurological Classification of Spinal Cord Injury (Isncsci)—what’s new? Spinal Cord. 2019;57(10):815–817. DOI:10.1038/s41393-019-0350-9
  • Kirshblum S, Snider B, Eren F, et al. Characterizing natural recovery after traumatic spinal cord injury. J Neurotrauma. 2021;38(9):1267–1284. DOI:10.1089/neu.2020.7473
  • Fehlings MG, Pedro K, Hejrati N. Management of acute spinal cord injury: where have we been? where are we now? where are we going? J Neurotrauma. 2022;39(23–24):1591–1602. DOI:10.1089/neu.2022.0009
  • Aarabi B, Alexander M, Mirvis SE, et al. Predictors of outcome in acute traumatic central cord syndrome due to spinal stenosis. J Neurosurg Spine. 2011;14(1):122–130. DOI:10.3171/2010.9.SPINE09922
  • Gupta S, Jaiswal A, Norman K, et al. Heterogeneity and its impact on rehabilitation outcomes and interventions for community reintegration in people with spinal cord injuries: an integrative review. Top Spinal Cord Inj Rehabil. 2019;25(2):164–185. DOI:10.1310/sci2502-164
  • Harvey LA. Physiotherapy rehabilitation for people with spinal cord injuries. J Physiother. 2016;62(1):4–11.
  • Dvorak MF, Noonan VK, Fallah N, et al. Minimizing errors in acute traumatic spinal cord injury trials by acknowledging the heterogeneity of spinal cord anatomy and injury severity: an observational Canadian cohort analysis. J Neurotrauma. 2014;31(18):1540–1547. DOI:10.1089/neu.2013.3278
  • Liu S-J, Wang Q, Tang H-H, et al. Heterogeneity among traumatic spinal cord injuries at the thoracolumbar junction: helping select patients for clinical trials. Spinal Cord. 2019;57(11):972–978. DOI:10.1038/s41393-019-0317-x
  • Vaccaro AR, Oner C, Kepler CK, et al. Aospine thoracolumbar spine injury classification system: fracture description, neurological status, and key modifiers. Spine. 2013;38(23):2028–2037. DOI:10.1097/BRS.0b013e3182a8a381
  • Albayar AA, Roche A, Swiatkowski P, et al. Biomarkers in spinal cord injury: prognostic insights and future potentials. Front Neurol. 2019;10:27.
  • Anwar MA, Al Shehabi TS, Eid AH. Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci. 2016;10:98.
  • Fizzotti G, Rognoni C, Imarisio A, et al. Tablet technology for rehabilitation after spinal cord injury: a proof-of-concept. Stud Health Technol Inform. 2015;210:479–483.
  • Laliberte AM, Karadimas SK, Vidal PM, et al. Mir21 modulates inflammation and sensorimotor deficits in cervical myelopathy: data from humans and animal models. Brain Commun. 2021;3(1):fcaa234. DOI:10.1093/braincomms/fcaa234
  • Desimone A, Hong J, Brockie ST, et al. The influence of ApoE4 on the clinical outcomes and pathophysiology of degenerative cervical myelopathy. JCI Insight. 2021;6(15):e149227. DOI:10.1172/jci.insight.149227
  • Toro CA, Das DK, Cai D, et al. Elucidating the role of apolipoprotein e isoforms in spinal cord injury-associated neuropathology. J Neurotrauma. 2019;36(24):3317–3322. DOI:10.1089/neu.2018.6334
  • Rubin-Asher D, Zeilig G, Ratner A, et al. Risk factors for failure of heparin thromboprophylaxis in patients with acute traumatic spinal cord injury. Thromb Res. 2010;125(6):501–504. DOI:10.1016/j.thromres.2009.09.012
  • Vidal Rodriguez S, Castillo Aguilar I, Cuesta Villa L, et al. TRPA1 polymorphisms in chronic and complete spinal cord injury patients with neuropathic pain: a pilot study. Spinal Cord Ser Cases. 2017;3(1):17089. DOI:10.1038/s41394-017-0004-0
  • Lin M, Huang W, Kabbani N, et al. Effect of CHRFAM7A Δ2bp gene variant on secondary inflammation after spinal cord injury. PLoS ONE. 2021;16(5):e0251110. DOI:10.1371/journal.pone.0251110
  • Freund P, Seif M, Weiskopf N, et al. MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol. 2019;18(12):1123–1135. DOI:10.1016/S1474-4422(19)30138-3
  • Aarabi B, Olexa J, Chryssikos T, et al. Extent of spinal cord decompression in motor complete (American spinal injury association impairment scale grades a and b) traumatic spinal cord injury patients: post-operative magnetic resonance imaging analysis of standard operative approaches. J Neurotrauma. 2019;36(6):862–876. DOI:10.1089/neu.2018.5834
  • Aarabi B, Sansur CA, Ibrahimi DM, et al. Intramedullary lesion length on postoperative magnetic resonance imaging is a strong predictor of ASIA Impairment Scale Grade Conversion Following Decompressive Surgery in Cervical Spinal Cord Injury. Neurosurgery. 2017;80(4):610–620. DOI:10.1093/neuros/nyw053
  • Badhiwala JH, Wilson JR, Kulkarni AV, et al. A Novel Method to Classify Cervical Incomplete Spinal Cord Injury Based on Potential for Recovery: a Group-Based Trajectory Analysis. J Neurotrauma. 2022;39(23–24):1654–1664. DOI:10.1089/neu.2022.0145
  • Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods. 2009;14(4):323–348.
  • Zhang Y, Al Mamun A, Yuan Y, et al. Acute spinal cord injury: pathophysiology and pharmacological intervention (Review). Mol Med Rep. 2021;23(6):417. DOI:10.3892/mmr.2021.12056
  • Wasner G, Naleschinski D, Baron R. A role for peripheral afferents in the pathophysiology and treatment of at-level neuropathic pain in spinal cord injury? A case report. Pain. 2007;131(1):219–225.
  • Sharma HS, Patnaik R, Sharma A, et al. Silicon Dioxide Nanoparticles (SiO 2 , 40–50 nm) Exacerbate Pathophysiology of Traumatic Spinal Cord Injury and Deteriorate Functional Outcome in the Rat. An Experimental Study Using Pharmacological and Morphological Approaches. J Nanosci Nanotechnol. 2009;9(8):4970–4980. DOI:10.1166/jnn.2009.1717
  • Schwartz G, Fehlings MG. Secondary injury mechanisms of spinal cord trauma: a novel therapeutic approach for the management of secondary pathophysiology with the sodium channel blocker riluzole. Prog Brain Res. 2002;137:177–190.
  • Kwon BK, Bloom O, Wanner I-B, et al. Neurochemical biomarkers in spinal cord injury. Spinal Cord. 2019;57(10):819–831. DOI:10.1038/s41393-019-0319-8
  • Salewski RP, Mitchell RA, Li L, et al. Transplantation of induced pluripotent stem cell-derived neural stem cells mediate functional recovery following thoracic spinal cord injury through remyelination of axons. Stem Cells Transl Med. 2015;4(7):743–754. DOI:10.5966/sctm.2014-0236
  • Kong D, Feng B, Amponsah AE, et al. hiPSC-derived NSCs effectively promote the functional recovery of acute spinal cord injury in mice. Stem Cell Res Ther. 2021;12(1):172. DOI:10.1186/s13287-021-02217-9
  • Orr MB, Gensel JC. Spinal cord injury scarring and inflammation: therapies targeting glial and inflammatory responses. Neurotherapeutics. 2018;15(3):541–553.
  • Barritt AW, Davies M, Marchand F, et al. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci Off J Soc Neurosci. 2006;26(42):10856–10867. DOI:10.1523/JNEUROSCI.2980-06.2006
  • Vecin NM, Gater DR. Pressure Injuries and Management after Spinal Cord Injury. J Pers Med. 2022;12(7):1130.
  • Chio JCT, Punjani N, Hejrati N, et al. Extracellular matrix and oxidative stress following traumatic spinal cord injury: physiological and pathophysiological roles and opportunities for therapeutic intervention. Antioxid Redox Signal. 2022;37(1–3):184–207. DOI:10.1089/ars.2021.0120
  • Liu S, Xie Y-Y, Wang B. Role and prospects of regenerative biomaterials in the repair of spinal cord injury. Neural Regen Res. 2019;14(8):1352.
  • Wu X, Liu J, Tanadini LG, et al. Challenges for defining minimal clinically important difference (MCID) after spinal cord injury. Spinal Cord. 2015;53(2):84–91. DOI:10.1038/sc.2014.232
  • Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–415.
  • Hill MR, Noonan VK, Sakakibara BM, et al. Quality of life instruments and definitions in individuals with spinal cord injury: a systematic review. Spinal Cord. 2010;48(6):438–450. DOI:10.1038/sc.2009.164
  • Sertkaya A, Wong H-H, Jessup A, et al. Key cost drivers of pharmaceutical clinical trials in the United States. Clin Trials Lond Engl. 2016;13(2):117–126. DOI:10.1177/1740774515625964
  • Moore TJ, Zhang H, Anderson G, et al. Estimated costs of pivotal trials for novel therapeutic agents approved by the US Food and Drug Administration, 2015-2016. JAMA Intern Med. 2018;178(11):1451–1457. DOI:10.1001/jamainternmed.2018.3931
  • Moore TJ, Heyward J, Anderson G, et al. Variation in the estimated costs of pivotal clinical benefit trials supporting the US approval of new therapeutic agents, 2015–2017: a cross-sectional study. BMJ Open. 2020;10(6):e038863. DOI:10.1136/bmjopen-2020-038863
  • Wong N. The changing landscape of research funding: challenges for mid-career researchers. Genome Biol. 2019;20(1):178.
  • Badhiwala JH, Wilson JR, Fehlings MG. Global burden of traumatic brain and spinal cord injury. Lancet Neurol. 2019;18(1):24–25. DOI:10.1016/S1474-4422(18)30444-7
  • Hejrati N, Moghaddamjou A, Pedro K, et al. Current practice of acute spinal cord injury management: a global survey of members from the AO Spine. Glob Spine J. 2022:21925682221116890. DOI:10.1177/21925682221116888.
  • United Nations Development Programme HDR. Statistical Update: human Development Indices and Indicators. Omaha: NE; HDR [Internet]. 2018; Available from: Published online 2018 http://hdr.undp.org/en/content/human-development-indices-indicators-2018.
  • Fehlings MG, Tetreault LA, Wilson JR, et al. A clinical practice guideline for the management of patients with acute spinal cord injury and central cord syndrome: recommendations on the timing (≤24 hours versus >24 hours) of decompressive surgery. Glob Spine J. 2017;7(3_suppl):195S–202S. DOI:10.1177/2192568217706367
  • Walters BC, Hadley MN, Hurlbert RJ, et al. Guidelines for the management of acute cervical spine and spinal cord injuries: 2013 update. Neurosurgery. 2013;60(Supplement 1):82–91. DOI:10.1227/01.neu.0000430319.32247.7f
  • Mills J-A, Marks E, Reynolds T, et al.et al. Rehabilitation: essential along the Continuum of Care. In: Jamison D, Gelband H Horton S, editors. In Dis Control Priorities Improve Health Reducing Poverty [Internet]. 3rd (WA) (DC): The International Bank for Reconstruction and Development/The World Bank. 2017 [cited 2023 Apr 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK525298/
  • Thompson C, Mutch J, Parent S, et al. The changing demographics of traumatic spinal cord injury: an 11-year study of 831 patients. J Spinal Cord Med. 2015;38(2):214–223. DOI:10.1179/2045772314Y.0000000233
  • Varacallo M, Davis DD, Pizzutillo P Osteoporosis in Spinal Cord Injuries. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 Apr 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK526109/.
  • Tricco AC, Thomas SM, Veroniki AA, et al. Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis. JAMA. 2017;318(17):1687–1699. DOI:10.1001/jama.2017.15006
  • Deiner S, Silverstein JH. LONG-TERM OUTCOMES in ELDERLY SURGICAL PATIENTS. Mt Sinai J Med N Y. 2012;79(1):95–106.
  • Millan M. Enhanced recovery after surgery in elderly and high-risk patients. Ann Laparosc Endosc Surg. 2020 [[cited 2023 Apr 24]];5:39. InternetAvailable from: https://ales.amegroups.com/article/view/5712
  • Everaert K, Lumen N, Kerckhaert W, et al. Urinary tract infections in spinal cord injury: prevention and treatment guidelines. Acta Clin Belg. 2009;64(4):335–340. DOI:10.1179/acb.2009.052
  • Scivoletto G, Morganti B, Ditunno P, et al. Effects on age on spinal cord lesion patients’ rehabilitation. Spinal Cord. 2003;41(8):457–464. DOI:10.1038/sj.sc.3101489
  • Ikpeze TC, Mesfin A. Spinal cord injury in the geriatric population: risk factors, treatment options, and long-term management. Geriatr Orthop Surg Rehabil. 2017;8(2):115–118.
  • Veronesi F, Borsari V, Martini L, et al. The impact of frailty on spine surgery: systematic review on 10 years clinical studies. Aging Dis. 2021;12(2):625–645. DOI:10.14336/AD.2020.0904
  • Fleming TR, Demets DL, McShane LM. Discussion: the role, position, and function of the FDA—The past, present, and future. Biostat Oxf Engl. 2017;18(3):417–421.
  • Vijayananthan A, Nawawi O. The importance of Good Clinical Practice guidelines and its role in clinical trials. Biomed Imaging Interv J. 2008;4(1):e5.
  • Wilkinson E. RECOVERY trial: the UK COVID-19 study resetting expectations for clinical trials. BMJ. 2020;369:m1626.
  • Canseco JA, Karamian BA, Bowles DR, et al. Updated review: the steroid controversy for management of spinal cord injury. World Neurosurg. 2021;150:1–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.